|
Primate Animal Model
Services
wPrimate
animal characteristics are close to human
characteristics. This is especially true in
tissue structure, immune system, physiology, and
metabolism. Nonhuman
primate animal
model
has become not only a
bridge to connect basic research and clinical
application, but also an ideal animal model for
human health and disease research.
w
wAccording
to FDA's regulation, all drug candidates
for Neurological diseases, such as
Alzheimer's disease, Parkinson's
disease, must pass nonhuman primate
animal test before processing into
clinical trial.
In addition, all cell-based therapies
and gene-therapies are also required to
go through nonhuman
primate animal test before
advancing
to a phase I
clinical trial.
Nonhuman
primate
animal models need to be established for
the research of the following important
human diseases, such as AIDS, SARS,
Autoimmune System diseases, Old age
diseases, and other gene defective
diseases.
Biochain has teamed up with
contract research organizations
(CROs), which are fully
accredited by AAALAC
international, and exclusively
focus on primate resources. We
have a very strong team of
scientists, researchers,
veterinarians, and technicians,
are engaged
in developing
nonhuman
primate model for studies
of drug safety, drug
pharmacokinetics, drug efficacy,
and
cell and gene therapies,
particularly for neurological
disorders and aging-related
diseases.
Currently we have
nonhuman primate models of
Parkinson's
disease and Diabetic disease.
We are able to provide
the following services
w
-
Disease Models: Parkinson's
disease and Diabetes
-
Drug efficacy test
-
Long-term toxicity including fetal
toxicity testing
-
PK and PD studies in primates
-
Cell therapy and gene therapy test
Advantage
-
Guarantee high
quality service in facilities accredited by AAALAC
-
Unique expertise and clinical resources on disease modeling,
including Parkinson's disease, diabetes (chemical induced and nature
model) and others
-
Strong research and project management team
including
many well-experience scientists with Ph.D. and M.D degree.
-
Strong support from central and local government and academic
institutions
-
Well established reputation and
successful collaboration with U.S. research institutions and Pharmaceutical
companies.
-
Access to rich primate resources
(more
than 30,000
cynomolgus monkeys)
-
Lower cost than
most of the other competitors
Age associated decrease in Striatal
99mTc-TRODAT-1 uptake ratio from a monkey of 4 years old (A), 10 years
old (B) and 15 years old(C) were measured by SPECT in our facility
|
Detail
Pricing |
Contact us at
[email protected] for details
concerning your research. |
|
send mail to [email protected] with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified:
05/19/16
|